337 related articles for article (PubMed ID: 19767653)
1. Prion protein and metal interaction: physiological and pathological implications.
Singh N; Das D; Singh A; Mohan ML
Curr Issues Mol Biol; 2010; 12(2):99-107. PubMed ID: 19767653
[TBL] [Abstract][Full Text] [Related]
2. Redox control of prion and disease pathogenesis.
Singh N; Singh A; Das D; Mohan ML
Antioxid Redox Signal; 2010 Jun; 12(11):1271-94. PubMed ID: 19803746
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
4. Evolving views in prion glycosylation: functional and pathological implications.
Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
[TBL] [Abstract][Full Text] [Related]
5. Prion protein modulates cellular iron uptake: a novel function with implications for prion disease pathogenesis.
Singh A; Mohan ML; Isaac AO; Luo X; Petrak J; Vyoral D; Singh N
PLoS One; 2009; 4(2):e4468. PubMed ID: 19212444
[TBL] [Abstract][Full Text] [Related]
6. Effects of metal binding on solubility and resistance of physiological prions depend on tissues and glycotypes.
Kuczius T; Kelsch R
J Cell Biochem; 2013 Dec; 114(12):2690-8. PubMed ID: 23794222
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of prion-induced modifications in membrane transport properties: implications for signal transduction and neurotoxicity.
Kourie JI
Chem Biol Interact; 2001 Oct; 138(1):1-26. PubMed ID: 11640912
[TBL] [Abstract][Full Text] [Related]
8. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.
Hara H; Okemoto-Nakamura Y; Shinkai-Ouchi F; Hanada K; Yamakawa Y; Hagiwara K
J Virol; 2012 May; 86(10):5626-36. PubMed ID: 22398286
[TBL] [Abstract][Full Text] [Related]
9. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
10. Aberrant metal binding by prion protein in human prion disease.
Wong BS; Chen SG; Colucci M; Xie Z; Pan T; Liu T; Li R; Gambetti P; Sy MS; Brown DR
J Neurochem; 2001 Sep; 78(6):1400-8. PubMed ID: 11579148
[TBL] [Abstract][Full Text] [Related]
11. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.
Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P
J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825
[TBL] [Abstract][Full Text] [Related]
12. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
13. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
14. Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases.
Choi CJ; Kanthasamy A; Anantharam V; Kanthasamy AG
Neurotoxicology; 2006 Sep; 27(5):777-87. PubMed ID: 16860868
[TBL] [Abstract][Full Text] [Related]
15. A Yin-Yang role for metals in prion disease.
Wong BS; Brown DR; Sy MS
Panminerva Med; 2001 Dec; 43(4):283-7. PubMed ID: 11677424
[TBL] [Abstract][Full Text] [Related]
16. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
[TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction.
Wang H; Tian C; Fan XY; Chen LN; Lv Y; Sun J; Zhao YJ; Zhang LB; Wang J; Shi Q; Gao C; Chen C; Shao QX; Dong XP
Int J Biochem Cell Biol; 2015 May; 62():24-35. PubMed ID: 25724737
[TBL] [Abstract][Full Text] [Related]
18. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
19. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
Prion; 2015; 9(5):394-403. PubMed ID: 26555211
[TBL] [Abstract][Full Text] [Related]
20. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
